Albemarle CorpALB
▲ PositiveCapitalDemandrelevance
Citi upgrades Albemarle to Buy, citing underappreciated growth opportunities and keeping $225 price target.
Impact on stocks 1
Critical Materials & Supply Chain▲ · 1 stocks
Albemarle CorpTheme Impact 1
Off-coverage companies
Related news
▼
Albemarle Fair Value Cut 7.8% to US$172.56 as Analysts Reset Lithium Assumptions
Albemarle's fair value estimate has been revised down from US$187.16 to US$172.56, a reduction of about 7.8%, as analysts reset their lithium assumptions. The revision reflects updated modeling assumptions, with revenue growth revised from 7.91% to 5.15%, the net profit margin assumption shifted from 34.27% to 35.74%, the future P/E multiple changed from 11.57x to 10.30x, and the discount rate adjusted from 7.41% to 7.50%. Wall Street targets moved broadly lower: Truist cut its target to US$225 from US$245, Scotiabank trimmed its target to US$190 from US$200 while maintaining an Outperform view, RBC Capital reduced its target to US$166 from US$257 while keeping an Outperform rating, and BofA moved its target to US$155 from US$225. On the bearish side, Morgan Stanley cut its target to US$161 from US$189, Mizuho lowered its target to US$185 from US$205 with a Neutral stance, and JPMorgan reduced its target to US$140 from US$160 while maintaining a Neutral rating after updating its model following the Q2 report.
Albemarle Shares Fall 14.3% as Analysts Cut Earnings Estimates
Albemarle has drawn heightened investor attention after its shares returned -14.3% over the past month, compared with a -1.3% change for the Zacks S&P 500 composite and a 6.3% loss for the Zacks Chemical - Diversified industry. For the current quarter, the company is expected to post earnings of $2.55 per share, a change of +1442.1% from the year-ago quarter, though the Zacks Consensus Estimate has fallen 15.9% over the last 30 days. For the current fiscal year, the consensus earnings estimate of $11.39 points to a change of +1541.8% from the prior year and has declined 4.4% over the past month, while the next fiscal year's estimate of $11.07 indicates a -2.8% change and has slipped 3.9%. The consensus sales estimate of $1.52 billion for the current quarter points to a year-over-year change of +16.1%, with $6.1 billion and $6.35 billion expected for the current and next fiscal years. Albemarle reported revenues of $1.74 billion in the last reported quarter, up 31.1% year over year, with EPS of $3.75 versus $0.11 a year ago, and carries a Zacks Rank #3 (Hold) and a Zacks Value Style Score of B.
ExxonMobil Low-Carbon Units Seen Adding $1 Billion a Year by 2030
ExxonMobil plans to invest roughly $20 billion in lower-emission projects between 2025 and 2030, and management expects newer business segments including carbon capture and storage, lithium, carbon materials, and Proxxima products to generate more than $1 billion in annual earnings by 2030, with roughly $13 billion in potential annual earnings by 2040 assuming supportive policies and sufficient market development. The company already holds contracts covering roughly 9 million metric tons of CO2 annually from industrial customers, and its first commercial carbon capture projects are now operating, which should give management enough commercial activity by 2027 to offer investors better visibility into what carbon capture can contribute financially. The bet is framed against a shifting oil demand picture: more than 20 million electric cars were sold globally in 2025, about one-quarter of all new-car sales, and the International Energy Agency expects EVs to approach 29% of global car sales in 2026, with the existing EV fleet displacing roughly 1.7 million barrels of oil demand per day in 2025 and potentially around 5 million barrels per day by 2030. ExxonMobil is also developing carbon-capture-enabled data center projects that would use natural gas to generate electricity while capturing the resulting emissions. The prediction is that 2027 is when ExxonMobil's low-carbon investments start showing up more clearly in guidance.